Kazuhito Noguchi

2.3k total citations · 2 hit papers
29 papers, 2.0k citations indexed

About

Kazuhito Noguchi is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kazuhito Noguchi has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Physiology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kazuhito Noguchi's work include Receptor Mechanisms and Signaling (14 papers), Nitric Oxide and Endothelin Effects (10 papers) and Neuropeptides and Animal Physiology (10 papers). Kazuhito Noguchi is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Nitric Oxide and Endothelin Effects (10 papers) and Neuropeptides and Animal Physiology (10 papers). Kazuhito Noguchi collaborates with scholars based in Japan, United States and Norway. Kazuhito Noguchi's co-authors include Toshihiko Saeki, Takahiro Fukuroda, Masaru Nishikibe, Mitsuo Yano, Sonoko Tsuchida, Masaki Ihara, Takehiro Fukami, Toshiaki Mase, Kiyofumi Ishikawa and Satoshi Ozaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Journal of Applied Physiology.

In The Last Decade

Kazuhito Noguchi

27 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor

1992 774 citations Masaki Ihara, Kazuhito Noguchi et al. Life Sciences profile →
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

1994 517 citations Kiyofumi Ishikawa, M. Ihara et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuhito Noguchi Japan	16	1.4k	797	633	222	220	29	2.0k
Toshihiko Saeki Japan	17	1.8k 1.3×	979 1.2×	818 1.3×	235 1.1×	267 1.2×	30	2.4k
Kiyofumi Ishikawa Japan	20	1.7k 1.2×	722 0.9×	881 1.4×	181 0.8×	439 2.0×	61	2.4k
Jinshyun R. Wu‐Wong United States	25	1.1k 0.8×	941 1.2×	456 0.7×	159 0.7×	510 2.3×	68	2.4k
Masaru Nishikibe Japan	18	1.6k 1.2×	730 0.9×	891 1.4×	171 0.8×	281 1.3×	52	2.1k
Terry J. Opgenorth United States	35	2.1k 1.5×	1.1k 1.4×	1.3k 2.0×	251 1.1×	806 3.7×	101	3.6k
Elwood E. Reynolds United States	24	682 0.5×	856 1.1×	495 0.8×	344 1.5×	127 0.6×	41	1.8k
Mitsuo Yano Japan	27	2.6k 1.8×	1.3k 1.6×	1.2k 2.0×	319 1.4×	413 1.9×	77	3.1k
Feraydoon Niroomand Germany	23	675 0.5×	890 1.1×	582 0.9×	128 0.6×	246 1.1×	45	2.0k
Georges Hirth Switzerland	11	849 0.6×	586 0.7×	555 0.9×	72 0.3×	252 1.1×	17	1.5k
Ponnal Nambi United States	29	616 0.4×	1.4k 1.8×	295 0.5×	564 2.5×	124 0.6×	92	2.4k

Countries citing papers authored by Kazuhito Noguchi

Since Specialization

Citations

This map shows the geographic impact of Kazuhito Noguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhito Noguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhito Noguchi more than expected).

Fields of papers citing papers by Kazuhito Noguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhito Noguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhito Noguchi. The network helps show where Kazuhito Noguchi may publish in the future.

Co-authorship network of co-authors of Kazuhito Noguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhito Noguchi. A scholar is included among the top collaborators of Kazuhito Noguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhito Noguchi. Kazuhito Noguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kato, Tamotsu, Yoshiyuki Matsuo, Koji Yamanegi, et al.. (2025). Identification of beneficial symbiont candidates in commensalism as potential oral gatekeepers. Microbiology Spectrum. 13(10). e0158825–e0158825.

Sagara, Takeshi, Sachie Otsuki, Toshifumi Kimura, et al.. (2006). Identification of a Novel 4-Aminomethylpiperidine Class of M₃Muscarinic Receptor Antagonists and Structural Insight into Their M₃Selectivity. Journal of Medicinal Chemistry. 49(19). 5653–5663. 8 indexed citations

Huang, Zheng, Susana Liu, Lei Zhang, et al.. (2005). Preferential inhibition of human phosphodiesterase 4 by ibudilast. Life Sciences. 78(23). 2663–2668. 51 indexed citations

Naya, Akira, Makoto Ishikawa, Kenji Matsuda, et al.. (2003). Structure–activity relationships of xanthene carboxamides, novel CCR1 receptor antagonists. Bioorganic & Medicinal Chemistry. 11(6). 875–884. 56 indexed citations

Kimura, Toshifumi, et al.. (2003). Identification of novel muscarinic M3 selective antagonists with a conformationally restricted Hyp-Pro spacer. Bioorganic & Medicinal Chemistry Letters. 13(1). 57–60. 12 indexed citations

Naya, Akira, Kensuke Kobayashi, Makoto Ishikawa, et al.. (2003). Structure-Activity Relationships of 2-(Benzothiazolylthio)acetamide Class of CCR3 Selective Antagonist. Chemical and Pharmaceutical Bulletin. 51(6). 697–701. 31 indexed citations

Ogino, Yoshio, Norikazu Ohtake, Kensuke Kobayashi, et al.. (2003). Muscarinic M3 receptor antagonists with (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2. Bioorganic & Medicinal Chemistry Letters. 13(13). 2167–2172. 12 indexed citations

Niiyama, Kenji, Toshiaki Mase, Akira Naya, et al.. (2002). 6-Carboxy-5,7-diarylcyclopenteno[1,2-b]pyridine derivatives. Bioorganic & Medicinal Chemistry. 10(8). 2461–2470. 10 indexed citations

Hirose, Hiroyasu, Ikuo Aoki, Toshifumi Kimura, et al.. (2002). The subtypes of muscarinic receptors for neurogenic bladder contraction in rats. European Journal of Pharmacology. 452(2). 245–253. 8 indexed citations

10.

Saeki, Toshihiko, Kenji Ohwaki, Akira Naya, et al.. (2001). Identification of a Potent and Nonpeptidyl CCR3 Antagonist. Biochemical and Biophysical Research Communications. 281(3). 779–782. 22 indexed citations

11.

Mitsuya, Morihiro, Yoshio Ogino, Toshifumi Kimura, et al.. (2000). Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivatives. Bioorganic & Medicinal Chemistry. 8(4). 825–832. 17 indexed citations

12.

Sato, Akio, Ikuo Aoki, Toru Fujikawa, et al.. (1999). Pharmacological characterization of J-104129, a novel muscarinic M3 receptor antagonist with high selectivity over M2 receptors. The Japanese Journal of Pharmacology. 79. 48–48. 3 indexed citations

13.

Mitsuya, Morihiro, Toshiaki Mase, Yoshimi Tsuchiya, et al.. (1999). J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors. Bioorganic & Medicinal Chemistry. 7(11). 2555–2567. 39 indexed citations

14.

Ishikawa, Kiyofumi, Takehiro Fukami, Toshiaki Mase, et al.. (1995). Endothelin Receptor Antagonists with Various Subtype-Specificity: Their Discovery and Use as Pharmacological Tools. European Journal of Medicinal Chemistry. 30. 371s–383s. 3 indexed citations

15.

Ishikawa, Kiyofumi, M. Ihara, Kazuhito Noguchi, et al.. (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.. Proceedings of the National Academy of Sciences. 91(11). 4892–4896. 517 indexed citations breakdown →

16.

Noguchi, Kazuhito, Yukiko Noguchi, Hiroyasu Hirose, et al.. (1993). Role of endothelin ETB receptors in bronchoconstrictor and vasoconstrictor responses in guinea pigs. European Journal of Pharmacology. 233(1). 47–51. 27 indexed citations

17.

Ihara, Masaki, Kazuhito Noguchi, Toshihiko Saeki, et al.. (1992). Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sciences. 50(4). 247–255. 774 indexed citations breakdown →

18.

Noguchi, Kazuhito, Takahiro Fukuroda, Hiroyasu Hirose, et al.. (1991). Local formation and degradation of endothelin-1 in guinea pig airway tissues. Biochemical and Biophysical Research Communications. 179(2). 830–835. 18 indexed citations

19.

Yano, Mitsuo, Kenji Okada, Junji Takada, et al.. (1991). Endothelin-Converting Enzyme and Its in vitro and in vivo Inhibition. Journal of Cardiovascular Pharmacology. 17. S26–28. 15 indexed citations

20.

Fukuroda, Takahiro, Kazuhito Noguchi, Sonoko Tsuchida, et al.. (1990). Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochemical and Biophysical Research Communications. 172(2). 390–395. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact